Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 8;19(1):256.
doi: 10.1186/s13023-024-03265-z.

Epidemiology, economic, and humanistic burden of hereditary angioedema: a systematic review

Affiliations

Epidemiology, economic, and humanistic burden of hereditary angioedema: a systematic review

Xin Guan et al. Orphanet J Rare Dis. .

Abstract

Background: This systematic study aims to assess the global epidemiologic, economic, and humanistic burden of illness associated with all types of hereditary angioedema.

Methods: A systematic search for articles reporting the epidemiologic, economic, and humanistic burden associated with patients with HAE was conducted using English and Chinese literature databases from the inception to May 23, 2022. The selected studies were assessed for their quality and risk of bias. The study was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses and registered with the International Prospective Register of Systematic Reviews (PROSPERO; CRD42022352377).

Results: In total, 65 articles that met the search inclusion criteria reported 10,310 patients with HAE, of whom 5861 were female patients. Altogether, 4312 patients (81%) and 479 patients (9%) had type 1 and type 2 HAE, respectively, whereas 422 patients (8%) had HAE-normal C1-INH. The overall prevalence of all types of HAE was between 0.13 and 1.6 cases per 100,000. The mean or median delay from the first onset of a symptom of HAE to confirmed diagnosis ranged from 3.9 to 26 years. The estimated risk of death from asphyxiation was 8.6% for patients with HAE. Hospitalization, medication, unnecessary surgeries, doctor visits, specialist services, and nursing costs are direct expenses that contribute to the growing economic burden. The indirect cost accounted mostly due to missing work ($3402/year) and loss of productivity ($5750/year). Furthermore, impairment of QoL as reported by patient-reported outcomes was observed. QoL measures identified depression, anxiety, and stress to be the most common symptoms for adult patients and children.

Conclusion: This study highlights the importance of early diagnosis and the need for improving awareness among health care professionals to reduce the burden of HAE on patients and society.

Keywords: Autosomal disorder; Clinical burden; Economic cost; Hereditary angioedema; Quality of life.

PubMed Disclaimer

Conflict of interest statement

Yanan Sheng, Miao He, and Tianxiang Chen are employees of Takeda (China) International Trading Co. Ltd. The other authors have no conflicts of interest to declare.

Figures

Fig. 1
Fig. 1
PRISMA flowchart for systematic review. HAE, hereditary angioedema

Similar articles

Cited by

References

    1. Riedl MA, Lumry WR, Busse P, Levy H, Steele T, Dayno J, et al. Prevalence of hereditary angioedema in untested first-degree blood relatives of known subjects with hereditary angioedema. Allergy Asthma Proc. 2015;36:206–12. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405600/ Cited 2022 Sep 20. - PMC - PubMed
    1. Maurer M, Magerl M, Betschel S, Aberer W, Ansotegui IJ, Aygören-Pürsün E, et al. The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update. World Allergy Org J. 2022;15:100627. https://linkinghub.elsevier.com/retrieve/pii/S1939455122000035 Cited 2022 Sep 23. - PMC - PubMed
    1. Cicardi M, Johnston DT. Hereditary and acquired complement component 1 esterase inhibitor deficiency: a review for the hematologist. Acta Haematol. 2012;127:208–220. doi: 10.1159/000336590. - DOI - PubMed
    1. Zanichelli A, Mansi M, Periti G, Cicardi M. Therapeutic management of hereditary angioedema due to C1 inhibitor deficiency. Expert Rev Clin Immunol. 2013;9:477–488. doi: 10.1586/eci.13.22. - DOI - PubMed
    1. Pines JM, Poarch K, Hughes S. Recognition and Differential Diagnosis of Hereditary Angioedema in the Emergency Department. J Emerg Med. 2021;60:35–43. doi: 10.1016/j.jemermed.2020.09.044. - DOI - PubMed

Publication types

LinkOut - more resources